55P0110, a Novel Synthetic Compound Developed from a Plant Derived Backbone Structure, Shows Promising Anti-Hyperglycaemic Activity in Mice

• Barbara Brunmair,

  Affiliation Division of Endocrinology & Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria

  ⨯
• Zsuzsanna Lehner,

  Affiliation Division of Endocrinology & Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria

  ⨯
• Karin Stadlbauer,

  Affiliation Division of Endocrinology & Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria

  ⨯
• Immanuel Adorjan,

  Affiliation 55pharma Drug Discovery & Development AG, Vienna, Austria

  ⨯
• Klaus Frobel,

  Affiliation 55pharma Drug Discovery & Development AG, Vienna, Austria

  ⨯
• Thomas Scherer,

  Affiliation Division of Endocrinology & Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria

  ⨯
• Anton Luger,

  Affiliation Division of Endocrinology & Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria

  ⨯
• Leonhardt Bauer,

  Affiliation 55pharma Drug Discovery & Development AG, Vienna, Austria

  ⨯
• Clemens Fürnsinn

  * E-mail: clemens.fuernsinn@meduniwien.ac.at

  Affiliation Division of Endocrinology & Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria

  ⨯